In vitro and in vivo quality of leukoreduced apheresis platelets stored in a new platelet additive solution

Transfusion

Volumn 53, Issue 5, 2013, Pages 972-980

  Dumont, Larry J ^a   Cancelas, Jose A ^a   Graminske, Sharon ^a   Friedman, Kenneth D ^a   Vassallo, Ralph R ^a   Whitley, Pamela H ^a   Rugg, Neeta ^a   Dumont, Deborah F ^a   Herschel, Louise ^a   Siegal, Alan H ^a   Szczepiorkowski, Zbigniew M ^a   Fender, Logan ^a   Razatos, Anna ^a  

^a BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG ADDITIVE; LACTIC ACID; PADGEM PROTEIN;

ARTICLE; CLINICAL PRACTICE; CONCENTRATION (PARAMETERS); GLUCOSE INTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LIMIT OF DETECTION; NORMAL HUMAN; PH; PROTEIN EXPRESSION; THROMBOCYTE LIFESPAN; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPHERESIS;

ANALYSIS OF VARIANCE; BLOOD PLATELETS; BLOOD PRESERVATION; CELL SURVIVAL; CROSS-OVER STUDIES; HUMANS; HYDROGEN-ION CONCENTRATION; LEUKOCYTE REDUCTION PROCEDURES; PHARMACEUTICAL SOLUTIONS; PLASMA; PLATELETPHERESIS; REGRESSION ANALYSIS;

EID: 84877703632     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03841.x     Document Type: Article

References (28)

1. Vassallo RR, Adamson JW, Gottschall JL, Snyder EL, Lee W, Houghton J, Elfath MD,. In vitro and in vivo evaluation of apheresis platelets stored for 5 days in 65% platelet additive solution/35% plasma. Transfusion 2010; 50: 2376-85.
2. Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A,. A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006; 108: 3210-5.
3. Silliman CC, Fung YL, Ball JB, Khan SY,. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev 2009; 23: 245-55.
4. Blumberg N, Heal JM, Gettings KF, Phipps RP, Masel D, Refaai MA, Kirkley SA, Fialkow LB,. An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions. Transfusion 2010; 50: 2738-44.
5. Becker JL,. First experiences transfusing platelets produced with additive solution. Transfusion 2011; 51 (Suppl): 189A.
6. Ringwald J, Walz S, Zimmermann R, Zingsem J, Strasser E, Weisbach V, Eckstein R,. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality. Vox Sang 2005; 89: 11-8.
7. Ringwald J, Haager B, Krex D, Zimmermann R, Strasser E, Antoon M, De Schrijver E, Eckstein R,. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets. Transfusion 2006; 46: 942-8.
8. 21CFR640.3. Additional Standards for Human Blood and Blood Products, Suitability of donor. 2012.
9. Price TH, editor. Additional apheresis donor qualification requirements. Chapter 5. Standards for blood banks and transfusion services. 26th ed. Bethesda (MD): American Association of Blood Banks; 2009. p. 18-21.
10. Holme S, Moroff G, Murphy S,. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998; 38: 31-40.
11. VandenBroeke T, Dumont LJ, Hunter S, Nixon J, Murphy S, Roger J, Herschel L, AuBuchon JP, Gulliksson H, Dengler T, Hornsey V, Prowse C,; for the Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Platelet storage solution effects on the accuracy of laboratory tests for platelet function: a multi-laboratory study. Vox Sang 2004; 86: 183-8.
12. Dumont LJ, VandenBroeke T, Ault KA,. Platelet surface P-selectin measurements in platelet preparations: an international collaborative study. Transfus Med Rev 1999; 13: 31-42.
13. Kunicki TJ, Tuccelli M, Becker GA, Aster RH,. A study of variables affecting the quality of platelets stored at "room temperature." Transfusion 1975; 15: 414-21.
14. The Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Platelet radiolabeling procedure. Transfusion 2006; 46 (Suppl): 59S-66S.
15. Lötter MG, Rabe WL, Van Zyl JM, Heyns AD, Wessels P, Kotzé HF, Minnaar PC,. A computer program in compiled Basic for the IBM personal computer to calculate the mean platelet survival time with the multiple hit and weighted mean methods. Comput Biol Med 1988; 18: 305-15.
16. Dumont LJ,. Analysis and reporting of platelet kinetic studies. Transfusion 2006; 46 (Suppl): 67S-73S.
17. Johnson L, Winter KM, Hartkopf-Theis T, Reid S, Kwok M, Marks DC,. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Transfusion 2012; 52: 503-9.
18. Dumont LJ, AuBuchon JP, Gulliksson H, Slichter SJ, Elfath MD, Holme S, Murphy JR, Rose LE, Popovsky MA, Murphy S,. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST collaborative. Transfusion 2006; 46: 1300-05.
19. Bertolini F, Murphy S, Rebulla P, Sirchia G,. Role of acetate during platelet storage in a synthetic medium. Transfusion 1992; 32: 152-6.
20. Dumont LJ, VandenBroeke T,. Seven-day storage of apheresis platelets: report of an in vitro study. Transfusion 2003; 43: 143-50.
21. VandenBroeke TL, Hillam H, Fenton C, Aga G, Rice J, Parr AM,. Donor-specificity of increased glycolysis rates in apheresis platelets. Transfusion 2010; 50 (Suppl): 65A.
22. Eisenberg RC, Dobrogosz WJ,. Gluconate metabolism in Escherichia coli. J Bacteriol 1967; 93: 941-9.
23. Kolodziejczyk J, Saluk-Juszczak J, Wachowicz B,. In vitro study of the antioxidative properties of the glucose derivatives against oxidation of plasma components. J Physiol Biochem 2011; 67: 175-83.
24. Saluk-Juszczak J,. A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and d-glucono-1,4-lactone in a human blood platelet model. Platelets 2010; 21: 632-40.
25. de Wildt-Eggen J, Schrijver JG, Bins M, Gulliksson H,. Storage of platelets in additive solutions: effects of magnesium and/or potassium. Transfusion 2002; 42: 76-80.
26. Vetlesen A, Mirlashari MR, Torsheim IA, Kjeldsen-Kragh J,. Platelet activation and residual activation potential during storage of hyperconcentrated platelet products in two different platelet additive solutions. Transfusion 2005; 45: 1349-55.
27. US Department of Health and Human Services. Draft guidance for industry for platelet testing and evaluation of platelet substitute products. US Department of Health and Human Services, May 1999. [cited 2012 Jun 6]. Available from: URL: http://www.fda.gov/downloads/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm080800.pdf? utm-campaign=Google2&utm-source=fdaSearch&utm-medium= website&utm-term=plateletsubstituteguidance&utm-content=3
28. McCullough J, Vesole DH, Benjamin RJ, Slichter SJ, Pineda A, Snyder E, Stadtmauer EA, Lopez-Plaza I, Coutre S, Strauss RG, Goodnough LT, Fridey JL, Raife T, Cable R, Murphy S, Howard F 4th, Davis K, Lin JS, Metzel P, Corash L, Koutsoukos A, Lin L, Buchholz DH, Conlan MG,. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004; 104: 1534-41.